These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35778842)
21. Molecular dynamics on complexes of ras-p21 and its inhibitor protein, rap-1A, bound to the ras-binding domain of the raf-p74 protein: identification of effector domains in the raf protein. Chen JM; Monaco R; Manolatos S; Brandt-Rauf PW; Friedman FK; Pincus MR J Protein Chem; 1997 Aug; 16(6):619-29. PubMed ID: 9263124 [TBL] [Abstract][Full Text] [Related]
22. Cryo-EM structure of a RAS/RAF recruitment complex. Park E; Rawson S; Schmoker A; Kim BW; Oh S; Song K; Jeon H; Eck MJ Nat Commun; 2023 Jul; 14(1):4580. PubMed ID: 37516774 [TBL] [Abstract][Full Text] [Related]
23. Quantitative biophysical analysis defines key components modulating recruitment of the GTPase KRAS to the plasma membrane. Lakshman B; Messing S; Schmid EM; Clogston JD; Gillette WK; Esposito D; Kessing B; Fletcher DA; Nissley DV; McCormick F; Stephen AG; Jean-Francois FL J Biol Chem; 2019 Feb; 294(6):2193-2207. PubMed ID: 30559287 [TBL] [Abstract][Full Text] [Related]
24. Identification, using molecular dynamics, of an effector domain of the ras-binding domain of the raf-p74 protein that is uniquely involved in oncogenic ras-p21 signaling. Chen JM; Rijhwani K; Friedman FK; Hyde MJ; Pincus MR J Protein Chem; 2000 Oct; 19(7):545-51. PubMed ID: 11233167 [TBL] [Abstract][Full Text] [Related]
25. Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles. Liao TJ; Jang H; Fushman D; Nussinov R Biophys J; 2018 Aug; 115(4):629-641. PubMed ID: 30097175 [TBL] [Abstract][Full Text] [Related]
26. Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD. Fetics SK; Guterres H; Kearney BM; Buhrman G; Ma B; Nussinov R; Mattos C Structure; 2015 Mar; 23(3):505-516. PubMed ID: 25684575 [TBL] [Abstract][Full Text] [Related]
27. How Anionic Lipids Affect Spatiotemporal Properties of KRAS4B on Model Membranes. Ngo VA; Sarkar S; Neale C; Garcia AE J Phys Chem B; 2020 Jul; 124(26):5434-5453. PubMed ID: 32438809 [TBL] [Abstract][Full Text] [Related]
28. The role of Hsp90N, a new member of the Hsp90 family, in signal transduction and neoplastic transformation. Grammatikakis N; Vultur A; Ramana CV; Siganou A; Schweinfest CW; Watson DK; Raptis L J Biol Chem; 2002 Mar; 277(10):8312-20. PubMed ID: 11751906 [TBL] [Abstract][Full Text] [Related]
29. Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ. Dharmaiah S; Bindu L; Tran TH; Gillette WK; Frank PH; Ghirlando R; Nissley DV; Esposito D; McCormick F; Stephen AG; Simanshu DK Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6766-E6775. PubMed ID: 27791178 [TBL] [Abstract][Full Text] [Related]
30. The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras. Ghosh S; Xie WQ; Quest AF; Mabrouk GM; Strum JC; Bell RM J Biol Chem; 1994 Apr; 269(13):10000-7. PubMed ID: 8144497 [TBL] [Abstract][Full Text] [Related]
31. Calmodulin disrupts plasma membrane localization of farnesylated KRAS4b by sequestering its lipid moiety. Grant BMM; Enomoto M; Back SI; Lee KY; Gebregiworgis T; Ishiyama N; Ikura M; Marshall CB Sci Signal; 2020 Mar; 13(625):. PubMed ID: 32234958 [TBL] [Abstract][Full Text] [Related]
32. SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling. Siljamäki E; Abankwa D Mol Cell Biol; 2016 Oct; 36(20):2612-25. PubMed ID: 27503857 [TBL] [Abstract][Full Text] [Related]
33. The Mystery of Rap1 Suppression of Oncogenic Ras. Nussinov R; Jang H; Zhang M; Tsai CJ; Sablina AA Trends Cancer; 2020 May; 6(5):369-379. PubMed ID: 32249186 [TBL] [Abstract][Full Text] [Related]
34. TC21 and Ras share indistinguishable transforming and differentiating activities. Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735 [TBL] [Abstract][Full Text] [Related]